Evidence map›Paper›PMID 28244152›Full record

ArticleThe European journal of neuroscience2017

Glycogen synthase kinase 3 regulates photic signaling in the suprachiasmatic nucleus.

Jodi R Paul, Alex S McKeown, Jennifer A Davis, Stacie K Totsch, Eric M Mintz, Timothy W Kraft, Rita M Cowell, Karen L Gamble

Open access · greenAbstract read
In one paragraph

Article in The European journal of neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jodi R PaulDepartments of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
Alex S McKeownDepartment of Vision Sciences, University of Alabama at Birmingham, Birmingham, AL, USA.
Jennifer A DavisDepartments of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
Stacie K TotschDepartment of Psychology, University of Alabama at Birmingham, Birmingham, AL, USA.
Eric M MintzDepartment of Biological Sciences, Kent State University, Kent, OH, USA.
Timothy W KraftDepartment of Vision Sciences, University of Alabama at Birmingham, Birmingham, AL, USA.
Rita M CowellDepartments of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
Karen L GambleDepartments of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.ORCID 0000-0003-3813-8577
University of Alabama at Birmingham · USKent State University · US

Funding

UAB Pre-Doctoral Training Program in Obesity-Related ResearchT32HL105349 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BARBARA A GOWER · 2010 to 2026
$5.7M
Circadian dysfunction and neurodegenerative diseaseR01NS082413 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GAMBLE, KAREN L · 2013 to 2022
$4.6M
GSK3 regulation of suprachiasmatic neuronal excitability and light entrainmentF31NS086282 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI PAUL, JODI RENEE · 2013 to 2014
$62k
NHLBI NIH HHS T32 HL105349NINDS NIH HHS F31 NS086282NINDS NIH HHS R01 NS082413
6 · The paper itself

Abstract

Glycogen synthase kinase 3 (GSK3) is a serine-threonine kinase that regulates mammalian circadian rhythms at the behavioral, molecular and neurophysiological levels. In the central circadian pacemaker, the suprachiasmatic nucleus (SCN), inhibitory phosphorylation of GSK3 exhibits a rhythm across the 24 h day. We have recently shown that GSK3 is capable of influencing both the molecular clock and SCN neuronal activity rhythms. However, it is not known whether GSK3 regulates the response to environmental cues such as light. The goal of this study was to test the hypothesis that GSK3 activation mediates light-induced SCN excitability and photic entrainment. Immunofluorescence staining in the SCN of mice showed that late-night light exposure significantly increased GSK3 activity (decreased pGSK3β levels) 30-60 min after the light-pulse. In addition, pharmacological inhibition of GSK3 blocked the expected light-induced excitability in SCN neurons; however, this effect was not associated with changes in resting membrane potential or input resistance. Behaviorally, mice with constitutively active GSK3 (GSK3-KI) re-entrained to a 6-h phase advance in the light-dark cycle in significantly fewer days than WT control animals. Furthermore, the behavioral and SCN neuronal activity of GSK3-KI mice was phase-advanced compared to WT, in both normal and light-exposed conditions. Finally, GSK3-KI mice exhibited normal negative-masking behavior and electroretinographic responses to light, suggesting that the enhanced photic entrainment is not due to an overall increased sensitivity to light in these animals. Taken together, these results provide strong evidence that GSK3 activation contributes to light-induced phase-resetting at both the neurophysiological and behavioral levels.

Indexed as

Action PotentialsAdaptation, PhysiologicalAnimalsCircadian ClocksCircadian RhythmFemaleGlycogen Synthase Kinase 3LightLight Signal TransductionMaleMiceMice, Inbred C57BLMice, TransgenicMotor ActivityNeuronsPhotoperiodGlycogen Synthase Kinase 3circadianelectrophysiologyentrainmentlightmouse

Identifiers

PMID28244152
PMCPMC5395359
OpenAlexW2591942067

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.